Picard Medical is trading at $10.73, down 5.38%, with no clear overnight company-specific catalyst identified ahead of October 13 trading. - A shareholder-law-firm investigation was publicized October 9, but available reporting does not establish it as the reason for the decline. - Healthcare sector weakness offers background context; broad-market moves were modest, and no specific cause for the drop is confirmed.